The expression of genes with MYCN-invaded enhancers depends on the tissue-specific transcription factor, such as TWIST1 in neuroblastoma, defining highly tumor-specific ‘MYC target gene signatures’, expanding from the canonical targets’ origined signature (74). The gene discussed is MYCN; the disease is neuroblastoma.